Transcriptomics

Dataset Information

0

The b-carboline harmine is an immunomodulator in cutaneous leishmaniasis favoring the balance towards a protective immune response


ABSTRACT: Here, we investigated the impact of synthetic b-carboline harmine (ACB1801), on the immune response and pathology resulting from infection with a drug-resistant Leishmania major strain causing non-healing cutaneous lesion. Exposure to ACB1801 impacted only slightly parasite viability and parasite burden in host macrophages in vitro. However, it significantly increased MHC-II and co stimulatory molecules expression on infected DCs, suggesting enhanced immune response. Accordingly, ACB1801 monotherapy significantly decreased lesion development and parasite burden in Leishmania infected C57BL/6 mice, with similar efficacy than the widely used Amphotericin B therapy. ACB1801 impact on the immune response was validated by transcriptomics analysis showing enrichment of TNF-a, IFN-g and MHC-II Ag presentation signatures in the draining lymph nodes of treated mice. Increased frequency of protective CD4+IFN-g+TNF-α+ T cells and reduced suppressive IL-10+FoxP3- T cells was observed by flow cytometry. ACB1801 was further shown to act via the downregulation of Aryl hydroxyl receptor (AhR) signaling, decreasing immunosuppressive cytokines. Thus, these results suggest a potential use for ACB1801 alone or in combination therapy.

ORGANISM(S): Mus musculus

PROVIDER: GSE236962 | GEO | 2023/10/24

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2019-02-19 | GSE56029 | GEO
2018-03-12 | PXD003217 | Pride
2017-11-16 | PXD006321 | Pride
2024-04-29 | GSE245292 | GEO
2024-04-29 | GSE260729 | GEO
2022-05-19 | GSE203088 | GEO
2018-10-11 | MSV000083023 | MassIVE
2014-03-07 | E-GEOD-55664 | biostudies-arrayexpress
2021-08-16 | GSE180949 | GEO
2008-05-21 | E-GEOD-10442 | biostudies-arrayexpress